Ligand validation:3VF5

031: (3aS,5R,6aR)-hexahydro-2H-cyclopenta[b]furan-5-yl [(1S,2R)-1-benzyl-2-hydroxy-3-([(4-methoxyphenyl)sulfonyl]{[(2R)-5-oxopyrrolidin-2-yl]methyl}amino)propyl]carbamate

031 is a Ligand Of Interest in 3VF5 designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
3VF5_031_B_201	90%	41%	0.093	0.977	1.06	1.21	4	6	0	0	100%	0.6619
3VF7_031_A_201	96%	26%	0.062	0.972	1.38	1.63	4	11	0	0	100%	0.9238
3H5B_031_B_404	93%	20%	0.082	0.975	1.38	1.99	2	16	3	0	100%	0.2
3VFB_031_A_201	86%	24%	0.085	0.952	1.33	1.77	3	12	0	0	100%	1
3VFA_031_A_201	84%	23%	0.107	0.969	1.28	1.88	2	12	1	0	100%	0.65
4J55_031_A_201	96%	29%	0.06	0.968	1.26	1.55	4	6	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.